Abstract
Splenomegaly is a clinical surrogate of oxaliplatin-induced sinusoidal obstruction syndrome (SOS). We investigated development of splenomegaly and its association with treatment outcome and genetic polymorphisms following adjuvant 5-fluorouracil, leucovorin, and oxaliplatin (FOLFOX) in colorectal cancer (CRC) patients. Splenomegaly was determined by spleen volumetry using computed tomography images obtained before initiation of chemotherapy and after completion of adjuvant FOLFOX in CRC patients. Ten genetic polymorphisms in 4 SOS-related genes (VEGFA, MMP9, NOS3, and GSTP1) were analyzed using DNA from peripheral blood mononuclear cells. Of 124 patients included, increase in spleen size was observed in 109 (87.9%). Median change was 31% (range, -42% to 168%). Patients with splenomegaly had more severe thrombocytopenia compared to patients without splenomegaly during the chemotherapy period (p < 0.0001). The cumulative dose of oxaliplatin and the lowest platelet count during the chemotherapy period were clinical factors associated with splenomegaly. However, no significant associations were found between genetic polymorphisms and development of splenomegaly. Disease-free survival was similar regardless of the development of spl...Continue Reading
References
May 29, 1999·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·L D DeLeveG C Kanel
Sep 12, 2001·Bone Marrow Transplantation·A IguchiI Maruyama
Dec 26, 2001·Bone Marrow Transplantation·R M Szydlo
May 30, 2002·Annals of Surgery·Michael A ChotiJohn L Cameron
Mar 5, 2004·Annals of Oncology : Official Journal of the European Society for Medical Oncology·L Rubbia-BrandtB Terris
Jun 4, 2004·The New England Journal of Medicine·Thierry AndréUNKNOWN Multicenter International Study of Oxaliplatin/5-Fluorouracil/Leucovorin in the Adjuvant Treatment of Colon Cancer (MOSAIC)
May 2, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Jean-Nicolas VautheyEddie K Abdalla
Mar 6, 2007·Current Gastroenterology Reports·Josh Levitsky, Michael F Sorrell
Oct 26, 2007·Cancer·Dario RiberoJean-Nicolas Vauthey
Dec 25, 2007·Annals of Surgery·Hiroshi NakanoDaniel Jaeck
Mar 27, 2009·Oncology·Revathi AngitapalliMarwan G Fakih
Feb 18, 2010·Annals of Surgery·Olivier SoubraneOlivier Scatton
Apr 22, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Michael J OvermanScott Kopetz
May 13, 2010·Histopathology·Laura Rubbia-BrandtBenoit Terris
Sep 17, 2010·Annals of Surgical Oncology·Dietmar TamandlThomas Gruenberger
Nov 9, 2010·Clinics in Liver Disease·Laura Rubbia-Brandt
Feb 19, 2011·Molecular Cancer Therapeutics·Laura Rubbia-BrandtBenoit Terris
Dec 28, 2011·Journal of Hepatology·Julie AgostiniPierre Laurent-Puig
Jan 13, 2012·CA: a Cancer Journal for Clinicians·Rebecca SiegelAhmedin Jemal
Apr 27, 2012·Annals of Oncology : Official Journal of the European Society for Medical Oncology·D L JardimP M Hoff
May 11, 2012·Histopathology·Celien P H VreulsAnn Driessen
Jan 5, 2013·British Journal of Cancer·C P H VreulsA Driessen
Mar 7, 2013·Annals of Surgical Oncology·Maartje A J van den BroekSteven W M Olde Damink
May 23, 2014·Cancer Research and Treatment : Official Journal of Korean Cancer Association·Kyu-Won JungJin Soo Lee
Aug 1, 2012·Annals of Oncology : Official Journal of the European Society for Medical Oncology·D L JardimP M Hoff
Citations
May 26, 2016·Cancer Chemotherapy and Pharmacology·Chunlei XuYong Tang
May 19, 2020·PloS One·Dominika Jedlińska-PijanowskaAnna Dobrzańska
Sep 3, 2020·PloS One·Justin G LeesGila Moalem-Taylor
Jun 2, 2017·Physics in Medicine and Biology·Oliver GlogerHenry Völzke
Aug 14, 2020·International Journal of Clinical Oncology·Ryo OhtaHideyuki Ishida
Sep 6, 2018·Annals of Surgical Treatment and Research·Jeonghyun KangJoon Jeong
Aug 6, 2021·Toxicology·Chen ZhuChengliang Zhang